Skip to content

Opening book details…

About this Medicine article

Interview for Breast Cancer Management with Dr David Montgomery: marketing authorization for Pfizer’s metastatic breast cancer treatment, palbociclib (Ibrance®) in combination with endocrine therapy by Montgomery, David is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Montgomery, David
Publisher
Future Medicine; Future Medicine Ltd.; Future Medicine Ltd (ISSN 1758-1923)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Montgomery, David

Browse all works by Montgomery, David